DK0459505T3 - Imidazonaphthyridinderivater - Google Patents

Imidazonaphthyridinderivater

Info

Publication number
DK0459505T3
DK0459505T3 DK91108908.4T DK91108908T DK0459505T3 DK 0459505 T3 DK0459505 T3 DK 0459505T3 DK 91108908 T DK91108908 T DK 91108908T DK 0459505 T3 DK0459505 T3 DK 0459505T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
substituted
represents hydrogen
hydroxy
unsubstituted
Prior art date
Application number
DK91108908.4T
Other languages
Danish (da)
English (en)
Inventor
Takeshi Kuroda
Fumio Suzuki
Kenji Ohmori
Shigeto Kitamura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of DK0459505T3 publication Critical patent/DK0459505T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91108908.4T 1990-06-01 1991-05-31 Imidazonaphthyridinderivater DK0459505T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14346090 1990-06-01
JP33465790 1990-11-30

Publications (1)

Publication Number Publication Date
DK0459505T3 true DK0459505T3 (da) 1996-11-18

Family

ID=26475184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91108908.4T DK0459505T3 (da) 1990-06-01 1991-05-31 Imidazonaphthyridinderivater

Country Status (9)

Country Link
US (3) US5364859A (ja)
EP (1) EP0459505B1 (ja)
JP (1) JP3016905B2 (ja)
AT (1) ATE143661T1 (ja)
CA (1) CA2043715C (ja)
DE (1) DE69122427T2 (ja)
DK (1) DK0459505T3 (ja)
ES (1) ES2094772T3 (ja)
GR (1) GR3021971T3 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043715C (en) * 1990-06-01 1997-01-07 Fumio Suzuki Imidazonaphthyridine derivatives
US5281610A (en) * 1991-07-31 1994-01-25 Kyowa Hakko Kogyo Co., Ltd. Condensed naphthyridine derivatives
JPH05194515A (ja) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd 縮合ナフチリジン誘導体
CA2124120A1 (en) * 1991-11-25 1993-06-10 Fumio Suzuki Imidazonaphthyridine derivatives
WO1994002481A1 (en) * 1992-07-20 1994-02-03 Kyowa Hakko Kogyo Co., Ltd. Imidazonaphthyridine derivative
US6365231B2 (en) 1998-06-26 2002-04-02 Kabushiki Kaisha Toshiba Ammonium halide eliminator, chemical vapor deposition system and chemical vapor deposition process
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
CA2381802C (en) 1999-08-21 2010-12-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of roflumilast and salmeterol
US6949247B2 (en) 2000-12-28 2005-09-27 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stable skin care compositions containing a retinoid and a retinoid booster system
JP4510383B2 (ja) 2001-05-23 2010-07-21 田辺三菱製薬株式会社 軟骨疾患修復治療用組成物
JP4510384B2 (ja) 2001-05-23 2010-07-21 田辺三菱製薬株式会社 骨折治癒促進用組成物
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
AU2006289838B2 (en) 2005-09-15 2011-08-18 Aska Pharmaceutical Co., Ltd. Heterocyclic compound, and production process and use thereof
CA2745071C (en) * 2008-12-17 2018-08-28 Yufang Xiao C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO66059A (ro) * 1973-05-25 1981-05-30 Gruppo Lepetit Spa,It Procedeu de obtinere a unor derivati de triazolochinoline
US4059584A (en) * 1974-08-07 1977-11-22 Pfizer 2-Acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
CA1271477A (en) * 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
US4760073A (en) * 1986-04-11 1988-07-26 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents
WO1989000571A2 (en) * 1987-07-22 1989-01-26 Schering Corporation Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
CA2043715C (en) * 1990-06-01 1997-01-07 Fumio Suzuki Imidazonaphthyridine derivatives

Also Published As

Publication number Publication date
JP3016905B2 (ja) 2000-03-06
DE69122427D1 (de) 1996-11-07
US5364859A (en) 1994-11-15
ES2094772T3 (es) 1997-02-01
EP0459505A1 (en) 1991-12-04
US5468756A (en) 1995-11-21
ATE143661T1 (de) 1996-10-15
GR3021971T3 (en) 1997-03-31
US5536730A (en) 1996-07-16
CA2043715C (en) 1997-01-07
EP0459505B1 (en) 1996-10-02
DE69122427T2 (de) 1997-03-06
CA2043715A1 (en) 1991-12-02
JPH04226985A (ja) 1992-08-17

Similar Documents

Publication Publication Date Title
DK0459505T3 (da) Imidazonaphthyridinderivater
ES2094204T3 (es) Derivados de piperazina.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
NO882626L (no) Fremgangsmaate for fremstilling av farmakologisk aktive pyridin-derivater.
NO910804D0 (no) Substituerte beta-diketoner.
ES2109936T3 (es) Derivados de piperacina.
SE8901060D0 (sv) New compounds
ATE148699T1 (de) Herstellung von 2-(2-thienyl)äthylamin und synthese von thieno(3,2-c)pyridinderivaten daraus
ATE140919T1 (de) Indolderivate
DE69103985D1 (de) N-Alkylthiazolidinderivate.
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung